Skip to main content
UCB's Global Corporate Website
instagram
facebook
twitter
youtube
linkedin
rss
Listen
30 Oct 2020
Disposals of own shares
Read More
29 Oct 2020
UCB Presents Nine Abstracts at EADV 2020, Showcasing Ongoing Commitment to Dermatology
Read More
23 Oct 2020
Disposals of own shares
Read More
22 Oct 2020
UCB’s anti-epileptic drug VIMPAT[®] (lacosamide) receives EU CHMP positive opinion for primary generalised tonic-clonic seizures
Read More
16 Oct 2020
UCB FURTHER INVESTS IN UK OPERATIONS WITH AGREEMENT TO ACQUIRE A NEW LEADING-EDGE CAMPUS
Read More
9 Oct 2020
Disposals of own shares
Read More
2 Oct 2020
Disposals of own shares
Read More
2 Oct 2020
Changes in UCB's Board of Directors
Read More
25 Sep 2020
Disposals of own shares
Read More
22 Sep 2020
UCB Achieves Important Regulatory Milestone for Bimekizumab
Read More
Pagination
First page
Previous page
‹ Previous
…
Page
9
Page
10
Page
11
Page
12
Current page
13
Page
14
Page
15
Page
16
Page
17
…
Next page
Next ›
Last page
Subscribe to
Choose a Country
Global Site – English
Australia – English
België – Engels
Belgique – Anglais
Brasil – Português
България – Български
Canada – English
Canada – Français
中国 – 中文
Česká Republika – Angličtina
Danmark – Engelsk
Deutschland – Deutsch
France – Français
España – Español
Ελλάδα – Ελληνικά
India – English
Ireland – English
Italia – Inglese
日本 – 日本語
한국 – 한국어
Luxembourg – Anglais
Luxemburg – Engels
Magyarország – Angol
México & Latinoamérica – Español
Nederland – Engels
New Zealand – English
Norge – Engelsk
Österreich – Deutsch
Polska – Polski
Portugal – español y portugués
România – Engleză
Россия – Русский
Slovensko – Anglický
Suomi – Englanti
Sverige – Engelska
Schweiz – Deutsch
Türkiye – Türkçe
Україна – Англійська
United Kingdom – English
U.S.A. – English
×
instagram
facebook
twitter
youtube
linkedin
rss